Sulindac increases the expression of APC mRNA in malignant colonic epithelial cells: An in vitro study

Gut

Volumn 38, Issue 5, 1996, Pages 707-713

  Schnitzler, M ^a   Dwight, T ^a   Robinson, B G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

APC gene; colonic carcinoma; familial polyposis syndrome; gene expression; sulindac

Indexed keywords

MESSENGER RNA; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; SULINDAC;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CANCER PREVENTION; COLON CARCINOGENESIS; COLON CARCINOMA; DOSE RESPONSE; DRUG EFFECT; ENZYME INHIBITION; FAMILIAL POLYPOSIS; HUMAN; HUMAN CELL; MESSENGER RNA SYNTHESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROSTAGLANDIN SYNTHESIS INHIBITION;

EID: 0030014026     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.38.5.707     Document Type: Article

References (45)

1. Duggan DE, Hooke KF, Risley EA, Shen TY, Arman CG. Identification of the biologically active form of sulindac. J Pharmacol Exp Ther 1977; 201: 8-13.
2. Waddell WR, Loughry RW. Sulindac for polyposis of the colon. J Surg Oncol 1983; 24: 83-7.
3. Giardiello FM, Hamilton SR, Krush AJ, Piantadosi S, Hylind LM, Celano P, et al. Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis. N Engl J Med 1993; 328: 1313-6.
4. Labayle D, Fischer D, Vielh P, Drouhin F, Pariente A, Bories C, et al. Sulindac causes regression of rectal polyps in familial adenomatous polyposis. Gastroenterology 1991; 101: 635-9.
5. Nugent KP, Farmer KC, Spigelman AD, Williams CB, Phillips RK. Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis. Br J Surg 1993; 80: 1618-9.
6. Rigau J, Pique JM, Rubio E, Planas R, Tarrech JM, Bordas JM. Effects of long-term sulindac therapy on colonic polyposis. Ann Intern Med 1991; 115: 952-4.
7. Hucker HB, Stauffer SC, White SD, Rhodes RE, Arison BH, Umbenhauer ER, et al. Physiologic disposition and metabolic fate of a new anti-inflammatory agent, cis-5-fluro-2-methyl-1-(p-(methylsulfinyl)-benzylidenyl)-indene-3-acetic acid in the rat, dog, rhesus monkey, and man. Drug Metab Dispos 1973; 1: 721-36.
8. Niv Y, Fraser GM. Adenocarcinoma in the rectal segment in familial polyposis coli is not prevented by sulindac therapy. Gastroenterology 1994; 107: 854-7.
9. Lynch HT, Thorson AG, Smyrk T. Rectal cancer after prolonged sulindac chemoprevention. A case report. Cancer 1995; 75: 936-8.
10. Waddell WR, Ganser GF, Cerise EJ, Loughry RW. Sulindac for polyposis of the colon. Am J Surg 1989; 157: 175-9.
11. Hixson LJ, Earnest DL, Fennerty MB, Sampliner RE. NSAID effect on sporadic colon polyps. Am J Gastroenterol 1993; 88: 1652-6.
12. Ladenheim J, Garcia G, Titzer D, Herzerberg H, Lavori P, Edson R, et al. Effect of sulindac on sporadic colonic polyps. Gastroenterology 1995; 108: 1083-7.
13. Craven PA, DeRubertis FR. Effects of aspirin on 1,2-dimethylhydrazine-induced colonic carcinogenesis. Carcinogenesis 1992; 13: 541-6.
14. Craven PA, Thornburg K, DeRubertis FR. Sustained increase in the proliferation of rat colonic mucosa during chronic treatment with aspirin. Gastroenterology 1988; 94: 567-75.
15. Ahnen D, Alberts D, Hixson L, Paranka N, Burt R, Pamukcu R. The sulfone metabolite of sulindac (FGN-1) inhibits rat colonic carcinogenesis but does not inhibit either prostaglandin synthesis of colonic proliferation. Gastroenterology 1995; 108: A444.
16. Ahnen D, Piazza F, Alberts D, Paranka N, Burt R, Pamukcu R. Sulindac sulfide (SS) and sulfone (FGN-1) both inhibit the growth of colon cancer cell lines by inducing apoptosis. Gastroenterology 1995; 108: A443.
17. Miyoshi Y, Nagase H, Ando H, Horii A, Ichii S, Nakatsuru S, et al. Somatic mutations of the APC gene in colorectal tumors: mutation cluster region in the APC gene. Human Molecular Genetics 1992; 1: 229-33.
18. Nagase H, Nakamura Y. Mutations of the APC (adenomatous polyposis coli) gene. Human Mutation 1993; 2: 425-34.
19. Rubinfeld B, Souza B, Albert I, Muller O, Chamberlain SH, Masiarz FR, et al. Association of the APC gene product with beta-catenin. Science 1993; 262: 1731-4.
20. Su LK, Vogelstein B, Kinzler KW. Association of the APC tumor suppressor protein with catenins. Science 1993; 262: 1734-7.
21. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis PX. Regulation of intracellular beta-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci USA 1905; 92: 3046-50.
22. Munemitsu S, Souza B, Muller O, Albert I, Rubinfeld B, Polakis P. The APC gene product associates with microtubules in vivo and promotes their assembly in vitro. Cancer Res 1994; 54: 3676-81.
23. Smith KJ, Levy DB, Maupin P, Pollard TD, Vogelstein B, Kinzler KW. Wild-type but not mutant APC associates with the microtubule cytoskeleton. Cancer Res 1994; 54: 3672-5.
24. Groden J, Thliveris A, Samowitz W, Carlson M, Gelbert L, Albertsen H, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
25. Kinzler KW, Nilbert MC, Su LK, Vogelstein B, Bryan TM, Levy DB, et al. Identification of FAP locus genes from chromosome 5q21. Science 1991; 253: 661-5.
26. Whitehead RH, Macrae FA, St John DJ, Ma J. A colon cancer cell line (LIM1215) derived from a patient with inherited nonpolyposis colorectal cancer. J Natl Cancer Inst 1985; 74: 759-65.
27. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidimum thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
28. Debinski HS, Trojan J, Nugent KP, Spigelman AD, Phillips RKS. Effect of sulindac on small polyps in familial adenomatous polyposis. Lancet 1995; 345: 855-6.
29. Pollard M, Luckert PH. Effect of indomethacin on intestinal tumors induced in rats by the acetate derivative of dimethylnitrosamine. Science 1981; 214: 558-9.
30. 2) against indomethacin. J Cancer Res Clin Oncol 1984; 108: 239-42.
31. Hixson LJ, Alberts DS, Krutzsch M, Einsphar J, Brendel K, Gross PH, et al. Antiproliferative effect of nonsteroidal antiinflammatory drugs against human colon cancer cells. Cancer Epidemiology, Biomakers and Prevention 1994; 3: 433-8.
32. Bennett A, Tacca MD, Stamford IF, Zebro T. Prostaglandins from tumours of human large bowel. Br J Cancer 1977; 35: 881-4.
33. 2 by the rat gastrointestinal tract. Stimulation by a hypertonic environment in vitro. Prostaglandins 1978; 15: 751-7.
34. 2. Gut 1994; 35: 675-8.
35. Hubbard WC, Alley MC, McLemore TL, Boyd MR. Profiles of prostaglandin biosynthesis in sixteen established cell lines derived from human lung, colon, prostate, and ovarian tumors. Cancer Res 1988; 48: 4770-5.
36. Bishop PR, Awad J, DuBois RN. Inhibition of immediate early gene expression by sulindac sulfide in rat intestinal epithelial cells. Gastroenterology 1994; 106: A372.
37. DuBois RN, Awad J, Morrow J, Roberts LJ, Bishop PR. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest 1994; 93: 493-8.
38. Shiff SJ, Tsai L, Qiao L, Rigas B. The effect of sulindac on cell proliferation and the cell cycle distribution of human colon cancer cells. Gastroenterology 1994; 106: A440.
39. Verma AK, Ashendel CL, Boutwell RK. Inhibition by prostaglandin synthesis inhibitors of the induction of epidermal ornithine decarboxylase activity, the accumulation of prostaglandins, and tumor promotion caused by 12-O-tetradecanoylphorbol-13-acetate. Cancer Res 1980; 40: 308-15.
40. Pasricha PJ, Bedi A, Rashid A, Hamilton SR, Akhtar AJ, O'Connor K, et al. Inhibition of apoptosis in familial adenomatous polyposis (FAP) and its modification by sulindac. Gastroenterology 1995; 108: A523.
41. Shiff SJ, Qiao L, Tsai L, Rigas B. Sulindac and sulindac sulfide reduce the level and activity of cyclin dependent kinases and induce apoptosis in HT-29 colon adenocarcinoma cells. Gastroenterology 1995; 108: A537.
42. Bodmer WF, Bailey CJ, Bodmer J, Bussey HJ, Ellis A, Gorman P, et al. Localization of the gene for familial adenomatous polyposis on chromosome 5. Nature 1987; 328: 614-6.
43. Su LK, Johnson KA, Smith KJ, Hill DE, Vogelstein B, Kinzler KW. Association between wild type and mutant APC gene products. Cancer Res 1993; 53: 2728-31.
44. Smith KJ, Johnson KA, Bryan TM, Hill DE, Markowitz S, Willson JK, et al. The APC gene product in normal and tumor cells. Proc Natl Acad Sci USA 1993; 90: 2846-50.
45. Lim S, Sigmund CD, Gross KW, Maquat L. Nonsense codons in human β-globin mRNA result in the production of mRNA degradation products. Mol Cell Biol 1992; 12: 1149-61.